Advanced Search

Display
per page
  Report Title Date Provider Type Pgs Price

Excelsior Medical Co Ltd: Business description, financial summary, 3yr and interim financials, key statistics/ratios and historical ratio analysis.

This report is essential reading for any serious investor, providing comprehensive financial information on a company's perfo...

14 May 2016 Reuters Investment Profile 12 $20.00

Thomson Reuters Stock Report - Excelsior Medical Co Ltd (4104-TW)

StockReports+ gathers Thomson Reuters independent research, ratings and market data into a single report that optimizes the i...

20 May 2016 Thomson Reuters Stock Report 11 $25.00

Excelsior Medical Co., Ltd. (4104) - Financial Analysis Review

Excelsior Medical Co., Ltd. (4104) - Financial Analysis Review Summary Excelsior Medical Co., Ltd. (Excelsior Medical) former...

16 May 2016 GlobalData 29 $300.00

Thomson Reuters Stock Report - Excelsior Medical Co Ltd (4104-TW)

StockReports+ gathers Thomson Reuters independent research, ratings and market data into a single report that optimizes the i...

29 Apr 2016 Thomson Reuters Stock Report 11 $25.00

Is Excelsior Medical Co Ltd Stock Still Attractive?

20 Apr 2016 Sadif Analytics Prime 12 $25.00

Wright Investors Service Comprehensive Report for Excelsior Medical Company Limited

Quantitative analyses of financial statements (Income Statement, Balance Sheet and Sources of Capital), extensive ratio table...

14 Apr 2016 Wright Reports 56 $75.00

Excelsior Medical Co., Ltd. (4104) - Financial Analysis Review

Excelsior Medical Co., Ltd. (4104) - Financial Analysis Review Summary Excelsior Medical Co., Ltd. (Excelsior Medical) former...

14 Mar 2016 GlobalData 31 $300.00

Is Excelsior Medical Co Ltd Worth a Higher Bid?

12 Jan 2016 Sadif Analytics Prime 12 $25.00

Excelsior Medical Co., Ltd. (4104) - Financial Analysis Review

Excelsior Medical Co., Ltd. (4104) - Financial Analysis Review Summary Excelsior Medical Co., Ltd. (Excelsior Medical) former...

11 Dec 2015 GlobalData 31 $300.00

佳醫 (4104) :營運僅靠洗腎業務帶動,目前評價合理

給予中立評等:展望2016年,台灣人口高齡化趨勢下,需進行血液透析人口仍小幅成長,且健保給付總價預估止跌小幅回升,醫療耗材部門仍為佳醫提供穩定成長。但長照事業因需攤提新增床位的支出,獲利貢獻不如2015年。醫美部門2016年沒有重量級的新品,藥材部門...

03 Nov 2015 MasterLink Securities Corporation 4 $23.00